A collaborative study was performed in conjunction with Pfizer Inc., Global Analytical Research and Development, by analyzing several different drug product (DP) formulations of (active pharmaceutical ingredient) API at different loading levels using Progeny.
Handheld Progeny Raman analyzers not only offer efficiency and fast data collection for final release of post-packaged DP, but also allows for an extra layer of quality to be incorporated into the post-packaging and post-package release testing, all while reducing material transfer steps and analyst exposure to high potency APIs and DPs.
To download this report, please complete this form:
Improved ergonomics for more convenient identification and detection of chemical threats and narcotics – even in non-visible amounts - using the 1064 nm Raman advantage
Handheld Raman for raw material identification and finished product authentication using 1064 nm Raman analysis.
The original handheld 1064 nm Raman analyzer to expand incident response by identifying more chemical threats and narcotics
Narcotics-focused analyzer to identify the latest opioid and fentanyl formulations